According to WHO, 49 laboratory-confirmed cases of human infection with novel Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported so far. Due to the severe acute respiratory disease of most...
PEPperPRINT is sponsoring the Deutsche Biotechnologietage 2013 taking place from May 14-15 in Stuttgart, Germany. We cordially invited to meet us at Booth 11 in the Exhibition Area to learn more on our new PEPperCHIP®...
We are pleased to announce that PEPperPRINT has signed a distribution agreement with Seoul-based AbClon Inc. Under the terms of the agreement AbClon has the exclusive marketing and sales rights for PEPperPRINT products...
PEPperPRINT released two new application notes on the use of the PEPperCHIP® Peptide Microarrays. The first application note describes the permutation scan of two known epitopes, HA and M13, for the in-depth analysis of...
The new PEPperCHIP® Autoimmunity Microarray covers 2,733 linear B-cell epitopes associated with autoimmune diseases from the Immune Epitope Database including 187 citrullinated peptides as well as the corresponding...
PEPperPRINT's high content peptide microarray platform PEPperCHIP® is introduced in present Science Magazine issue (Vol. 339, issue 6121, 2013) along with other new life science products from Roche and Qiagen. Science's...
PEPperPRINT has signed a distribution agreement with Cupertino, CA based B-Bridge International. Under the terms of the agreement B-Bridge has the marketing and sales rights for PEPperPRINT products in North America and...
